LIPODISSOLVE

(check out the Before/After pictures below)

Lipodissolve is a combination of pharmaceutical agents in an injectable form administered using technique developed in Austria in 2002 for the purpose of subcutaneous fact reduction.  According to recent journal articles and various Internet sites, Lipodissolve is considered a form of mesotherapy.  However, the 348 worldwide physician practitioners of Lipodissolve do not consider this process to be mesotherapy.

Lipodissolve injections reduce the size of localized fat deposits and cause skin retraction in body regions containing small deposits of localized fat, cellulite, or postlipoplasty deformities.  It will not replace traditional lipoplasty techniques, but is an excellent adjunct or alternative for those patients seeking minimally invasive treatment. 

Dr. Zuzukin attended a workshop on May 13, 2006 in Denver, Colorado for Lipolysis Injection Practice, where hands on training was administered by Franz Hasengschwandtner, MD, the developer of Lipolysis and the President of the International Society of Lipolysistherapy. Dr. Zuzukin is a member of the International Society of Lipolysistherapy as well.

Author's Current Study of Lipodissolve Efficacy and Safety

More than 18,000 injections of Lipodissolve have been performed by the 429 physician members of the European Network Lipodissolve and the American Society for Aesthetic Lipodissolve.  Based on the treatment protocol of these 2 organizations, the Author performed a clinical study between October 2004 and May 2005 in which 43 patients were injected in a total of 117 injection sites.  (Dr. Diane Irvine Duncan, MD, Ft. Collins, CO.)

	A. Pretreatment view of a 53-year-old woman who was undergoing abdominoplasty and wished to impoved her overhanging back roll. B. Postreatment view following abdominoplasty.  fifty mL of Lipodissolve was injected bilaterally druing one session. Dramatic reduction in the fat deposit was accompanied by smooth skin retraction.
	A. Pretreatment view of a 28-year-old woman who requested treatment for rippling in the thigh area following lipoplasty; she had no real residual fat, just skin contour irregularities. B. Some improvement was seen in the treated areas after 2 sessions.
	A. Pretreatment view of a 51-year-old woman who complained of skin laxity in the epigastric region.  She was injected in 2 sessions, using the standard Lipodissolve formula.  B. Significant improvement is shown following the first injection. C. Four weeks after the first injection session, she underwent a second treatment in the same area.  She received a more superficial injection technique resulting in a much more dramatic improvement in skin retraction.